Spi1 Phenotype Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Spi1
Spi-1 proto-oncogene
MGI:98282

98 phenotypes from 17 alleles in 21 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
\Cd19^tm1(cre)Cgn/\Cd19⁺ \Spi1^tm2Dgt/\Spi1^tm2Dgt involves: 129P2/OlaHsd * C57BL/6	normal hematopoietic system phenotype	J:114150
\Spi1^tm1.1Dgt/\Spi1^tm1.1Dgt involves: 129S1/Sv * 129X1/SvJ	abnormal bone marrow morphology	J:90331
	abnormal definitive hematopoiesis	J:90331
	abnormal erythrocyte cell number	J:90331
	abnormal spleen morphology	J:90331
	decreased B cell number	J:90331
	enlarged liver	J:90331
	enlarged spleen	J:90331
	increased leukemia incidence	J:90331
	increased T cell derived lymphoma incidence	J:90331
	increased tumor incidence	J:90331
	premature death	J:90331
	spleen hyperplasia	J:90331
\Spi1^tm1.1Nutt/\Spi1^tm1.1Nutt involves: C57BL/6 * BALB/cJ	absent common myeloid progenitor cells	J:98188
\Spi1^tm1.1Rpd/\Spi1^tm1.1Rpd involves: 129/Sv * Black Swiss * FVB/N	abnormal common myeloid progenitor cell morphology	J:138501
	postnatal lethality, complete penetrance	J:138501
\Spi1^tm1.2Dgt/\Spi1^tm1.2Dgt involves: 129S1/Sv * 129X1/SvJ * C57BL/6	no abnormal phenotype detected	J:106788
\Spi1^tm1.2Nutt/\Spi1^tm1.2Nutt \Tg(Mx1-cre)1Cgn/0 involves: C57BL/6 * CBA	abnormal bone marrow cell morphology/development	J:98188
	abnormal granulocyte differentiation	J:98188
	abnormal spleen morphology	J:98188
	absent common myeloid progenitor cells	J:98188
	absent erythrocytes	J:98188
	decreased B cell number	J:98188
	extramedullary hematopoiesis	J:98188
	increased granulocyte number	J:98188
\Spi1^tm1.3Dgt/\Spi1^tm1.3Dgt involves: 129 * BALB/c * C57BL/6	abnormal chromosome number	J:90331
	abnormal definitive hematopoiesis	J:90331
	abnormal liver morphology	J:90331
	abnormal proerythroblast morphology	J:90331
	abnormal spleen morphology	J:90331
	decreased B cell number	J:90331
	enlarged spleen	J:90331
	increased leukemia incidence	J:90331
	increased liver weight	J:90331
	increased neutrophil cell number	J:90331
	increased spleen weight	J:90331
	increased T cell derived lymphoma incidence	J:90331
	liver hyperplasia	J:90331
	premature death	J:90331
	spleen hyperplasia	J:90331
\Spi1^tm1.3Dgt/\Spi1^tm1.3Dgt involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6	abnormal double-negative T cell morphology	J:106040
	abnormal T cell subpopulation ratio	J:106040
	arrested B cell differentiation	J:106040
	decreased B-1a cell number	J:106040
	decreased granulocyte number	J:106040
	decreased mature B cell number	J:106040
	decreased pre-B cell number	J:106040
	decreased pro-B cell number	J:106040
	decreased T cell number	J:106040
	decreased thymocyte number	J:106040
	increased B-1 B cell number	J:106040
	increased B-1b cell number	J:106040
	increased IgM level	J:106040
	increased leukemia incidence	J:106040
	increased lymphocyte cell number	J:106040
	increased T cell derived lymphoma incidence	J:106040
	increased T cell number	J:106040
	premature death	J:106040
	small thymus	J:106040
\Spi1^tm1.3Nutt/\Spi1^tm1.3Nutt C57BL/6-Sfpi1^tm1.3Nutt	absent common myeloid progenitor cells	J:98188
\Spi1^tm1.3Nutt/\Spi1^tm1.3Nutt C57BL/6-Sfpi1^tm1.3Nutt	neonatal lethality, complete penetrance	J:98188
\Spi1^tm1Kast/\Spi1⁺ B6.129S2-Spi1^tm1Kast	abnormal erythropoiesis	J:90543
	increased bone marrow cell number	J:196609
	increased hematopoietic stem cell number	J:196609
\Spi1^tm1Kast/\Spi1^tm1Kast B6.129S2-Spi1^tm1Kast	abnormal erythropoiesis	J:90543
	abnormal fetal derived definitive erythrocyte cell number	J:90543
	absent B cells	J:90543
	failure of myelopoiesis	J:90543
	neonatal lethality, complete penetrance	J:90543
\Spi1^tm1Nutt/\Spi1^tm1Nutt involves: C57BL/6	no abnormal phenotype detected	J:95651
\Spi1^tm1Ram/\Spi1⁺ involves: 129S2/SvPas	abnormal eye development	J:101493
\Spi1^tm1Ram/\Spi1⁺ involves: 129S2/SvPas	persistence of hyaloid vascular system	J:101493
\Spi1^tm1Ram/\Spi1^tm1Ram involves: 129S2/SvPas	abnormal eye development	J:101493
	decreased macrophage cell number	J:101493
	normal homeostasis/metabolism phenotype	J:95801
	persistence of hyaloid vascular system	J:101493
\Spi1^tm1Ram/\Spi1^tm1Ram involves: 129S2/SvPas * C57BL/6	abnormal astrocyte morphology	J:116087
	abnormal B cell number	J:36473
	abnormal macrophage differentiation	J:36473
	abnormal microglial cell morphology	J:116087
	abnormal neutrophil differentiation	J:36473
	abnormal T cell differentiation	J:36473
	abnormal T cell number	J:36473
	absent mature B cells	J:36473
	dark liver	J:36473
	decreased CD4-positive, alpha-beta T cell number	J:36473
	decreased CD8-positive, alpha-beta T cell number	J:36473
	decreased double-positive T cell number	J:36473
	decreased macrophage cell number	J:36473
	decreased neutrophil cell number	J:36473
	decreased spleen red pulp amount	J:36473
	decreased thymocyte number	J:36473
	neonatal lethality, complete penetrance	J:36473
	postnatal growth retardation	J:116087
	premature death	J:116087
	sepsis	J:36473
\Spi1^tm1Rpd/\Spi1^tm1Rpd involves: 129	abnormal common myeloid progenitor cell morphology	J:138501
\Spi1^tm1Rpd/\Spi1^tm1Rpd involves: 129	postnatal lethality, incomplete penetrance	J:138501
\Spi1^tm1Rpd/\Spi1^tm1Rpd involves: 129/Sv * C57BL/6 * Black Swiss	abnormal common myeloid progenitor cell morphology	J:123079
	abnormal myelopoiesis	J:123079
	arrested B cell differentiation	J:123079
	decreased body size	J:123079
	enlarged spleen	J:123079
	failure of tooth eruption	J:123079
	impaired myelopoiesis	J:123079
	liver hyperplasia	J:123079
	osteopetrosis	J:123079
	postnatal lethality, incomplete penetrance	J:123079
\Spi1^tm1Sing/\Spi1^tm1Sing involves: 129S/SvEv	abnormal B cell differentiation	J:20348
	abnormal common myeloid progenitor cell morphology	J:138501
	abnormal erythropoiesis	J:20348
	abnormal granulocyte morphology	J:20348
	abnormal leukopoiesis	J:20348
	abnormal monocyte morphology	J:20348
	abnormal T cell differentiation	J:20348
	anemia	J:20348
	decreased hematocrit	J:20348
	lethality throughout fetal growth and development, complete penetrance	J:20348, J:138501
\Spi1^tm2.1Dgt/\Spi1^tm2.1Dgt B6.Cg-Spi1^tm2.1Dgt	abnormal blood cell morphology/development	J:114150
	abnormal hematopoietic system physiology	J:114150
	decreased hematopoietic stem cell number	J:114150
	prenatal lethality, complete penetrance	J:114150
\Spi1^tm2.1Dgt/\Spi1^tm2Dgt \Tg(Mx1-cre)1Cgn/0 involves: 129P2/OlaHsd * C57BL/6 * CBA	abnormal blood cell morphology/development	J:114150
\Spi1^{tm2b(EUCOMM)Wtsi}/\Spi1⁺ C57BL/6N-Spi1^{tm2b(EUCOMM)Wtsi}/J	decreased erythrocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
\Spi1^{tm2b(EUCOMM)Wtsi}/\Spi1^{tm2b(EUCOMM)Wtsi} C57BL/6N-Spi1^{tm2b(EUCOMM)Wtsi}/J	hemorrhage	J:211773
	preweaning lethality, complete penetrance	J:211773
\Spi1^tm2Dgt/\Spi1^tm2Dgt B6.Cg-Spi1^tm2Dgt	abnormal blood cell morphology/development	J:114150
\Spi1^tm2Dgt/\Spi1^tm2Dgt \Tg(Mx1-cre)1Cgn/0 involves: 129P2/OlaHsd * C57BL/6 * CBA	abnormal blood cell morphology/development	J:114150
\Spi1^tm3Dgt/\Spi1^tm3Dgt involves: 129S1/Sv * 129X1/SvJ * C57BL/6	decreased B cell number	J:131217
	decreased double-negative T cell number	J:131217
	increased double-negative T cell number	J:131217
	increased granulocyte number	J:131217
\Spi1^tm4.1Dgt/\Spi1^tm4.1Dgt B6.129(Cg)-Spi1^tm4.1Dgt	abnormal cell cycle	J:196609
	abnormal hematopoietic stem cell physiology	J:196609
	normal hematopoietic system phenotype	J:196609
	increased bone marrow cell number	J:196609
	increased hematopoietic stem cell number	J:196609
	increased hematopoietic stem cell proliferation	J:196609

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 03/25/2025 MGI 6.24